In a filing to Shanghai's stock exchange, CanSino said it would manufacture and supply unspecified mRNA products to AstraZeneca. It did not disclose the value of the deal. AstraZeneca said the deal would support investigational mRNA vaccines in its early pipeline.
from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/V1v6TZB
Home »
Information and Updates: ET HealthWorld : ETHealthworld.com
,
Top Health News | Latest Healthcare Sector & Healthcare Industry news
» China's CanSino in mRNA vaccine deal with AstraZeneca
https://ift.tt/ogfqjIO
No comments:
Post a Comment